Clinical and prognostic pan-cancer analysis of m6A RNA methylation regulators in four types of endocrine system tumors
Open Access
- 20 November 2020
- journal article
- research article
- Published by Impact Journals, LLC in Aging
- Vol. 12 (23) , 23931-23944
Abstract
N6-methyladenosine (m6A), internal modification of mRNA, has recently been reported to be an important regulatory mechanism affecting tumor proliferation. However, its role in endocrine system tumors is poorly understood. We obtained datasets for four types tumors from the TCGA database, analyzed the GTEx database as a supplement to the control group, and used "Perl" and "R" softwares to analyze the datasets. Then we differentiated the expression level, used it to cluster consensus. Besides, we established lasso regression model to screen variables, used univariate and multivariate cox analyses to explore the independent risk factors associated with cancer prognosis. The results indicated that except for WTAP, the expression level of METTL3 was negatively correlated with other genes. The expression level of WTAP and METTL16 was positively correlated with overall survival (OS). Moreover, we found that different clinical subtypes of adrenal cortical carcinoma had significant differences in survival status, histologic grading, pathological T grade, and OS. Furthermore, different clinical subtypes of thyroid carcinoma had significant differences in histologic grading and pathological T grade. The differential expression of m6A regulatory genes is closely associated with the presence of endocrine-system-related tumors, and risk scores can be used to assess prognosis.Keywords
This publication has 51 references indexed in Scilit:
- Genetic alterations of m6A regulators predict poorer survival in acute myeloid leukemiaJournal of Hematology & Oncology, 2017
- YTHDF3 facilitates translation and decay of N6-methyladenosine-modified RNACell Research, 2017
- Emerging links between m6A and misregulated mRNA methylation in cancerGenome Medicine, 2017
- MiR-33a suppresses proliferation of NSCLC cells via targeting METTL3 mRNABiochemical and Biophysical Research Communications, 2017
- METTL14 suppresses the metastatic potential of hepatocellular carcinoma by modulating N 6‐methyladenosine‐dependent primary MicroRNA processingHepatology, 2016
- METTL3 Gains R/W Access to the EpitranscriptomeMolecular Cell, 2016
- The m 6 A Methyltransferase METTL3 Promotes Translation in Human Cancer CellsMolecular Cell, 2016
- Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m 6 A-demethylation of NANOG mRNAProceedings of the National Academy of Sciences, 2016
- A METTL3–METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylationNature Chemical Biology, 2013
- Selection of important variables and determination of functional form for continuous predictors in multivariable model buildingStatistics in Medicine, 2007